Three femtosecond laser comparisons: IntraLase FS30 comes out on top

Article

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

A prospective study of the three LASIK procedures was performed in 303 eyes of 167 patients. Each procedure was carried out by the same surgeon. The Hansatome XP microkeratome with 120 µm head was used on 92 eyes (Group A). The IntraLase FS2 15 Hertz laser was used to create a 120 µm flap in 100 eyes (Group B) and the IntraLase FS30 30 Hertz laser was used to create a 120 µm flap in 111 eyes (Group C). Flap thickness was measured by subtraction of intraoperative stromal pachymetry from intraoperative corneal pachymetry.

The mean flap thickness was 133.37±20.37 µm in Group A, 132.25±19.90 µm in Group B and 116.45±18.13 µm in Group C.

The researchers found that the IntraLase femtosecond FS30 created more predictable and stable flap thicknesses than the other two lasers. No significant differences were found between the Hansatome XP and the IntraLase FS2.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.